Pages that link to "Q34344843"
Jump to navigation
Jump to search
The following pages link to Inhibitory effects of ibogaine on cocaine self-administration in rats (Q34344843):
Displaying 50 items.
- Hallucinogens: An update (Q22252593) (← links)
- Glial cell line-derived neurotrophic factor reverses ethanol-mediated increases in tyrosine hydroxylase immunoreactivity via altering the activity of heat shock protein 90 (Q24311534) (← links)
- Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption (Q24530154) (← links)
- Kappa opioids as potential treatments for stimulant dependence (Q24647849) (← links)
- Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment (Q28191634) (← links)
- The role of the habenula in drug addiction. (Q28238267) (← links)
- Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration (Q28297349) (← links)
- In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists. (Q33856557) (← links)
- Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine (Q34101436) (← links)
- Fatalities temporally associated with the ingestion of ibogaine (Q34249047) (← links)
- Ibogaine produces neurodegeneration in rat, but not mouse, cerebellum. Neurohistological biomarkers of Purkinje cell loss (Q34410645) (← links)
- Ibogaine: a review (Q34435889) (← links)
- Changes in gene expression and signal transduction following ibogaine treatment (Q34435906) (← links)
- Sigma receptors and iboga alkaloids (Q34435917) (← links)
- Ibogaine neurotoxicity assessment: electrophysiological, neurochemical, and neurohistological methods (Q34435923) (← links)
- Modulation of the effects of rewarding drugs by ibogaine (Q34435931) (← links)
- Clinical applications of hallucinogens: A review (Q34535259) (← links)
- Traditional medicine in the treatment of drug addiction (Q34603231) (← links)
- The Role of the Habenula in Nicotine Addiction (Q35875345) (← links)
- GDNF and addiction (Q36414656) (← links)
- Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment (Q36589468) (← links)
- Assessment of Neurotoxicity from Potential Medications for Drug Abuse: Ibogaine Testing and Brain Imaging (Q36873099) (← links)
- Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review (Q37225016) (← links)
- New therapeutic potential for psychoactive natural products (Q37660087) (← links)
- The medial habenula: still neglected (Q38183375) (← links)
- Designing modulators of 5-hydroxytryptamine signaling to treat abuse disorders (Q38248774) (← links)
- Ibogaine and addiction in the animal model, a systematic review and meta-analysis. (Q38849032) (← links)
- Generation of Complex Azabicycles and Carbobicycles from Two Simple Compounds in a Single Operation through a Metal-Free Six-Step Domino Reaction. (Q40885277) (← links)
- Ibogaine and cocaine abuse: pharmacological interactions at dopamine and serotonin receptors (Q41313856) (← links)
- Pharmacological comparison of the effect of ibogaine and 18-methoxycoronaridine on isolated smooth muscle from the rat and guinea-pig (Q41785459) (← links)
- Time-dependent interactions between iboga agents and cocaine (Q42546305) (← links)
- Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties (Q42657093) (← links)
- In vivo ibogaine blockade and in vitro PKC action of cocaine (Q42681094) (← links)
- Neurochemical and behavioural interactions between ibogaine and nicotine in the rat. (Q42705902) (← links)
- The acute effects of norharman on cocaine self-administration and sensorimotor function in male Wistar rats (Q43647939) (← links)
- The impact of smoking and drinking on plasma levels of norharman (Q43852509) (← links)
- Ibogaine and noribogaine potentiate the inhibition of adenylyl cyclase activity by opioid and 5-HT receptors (Q44344640) (← links)
- Evidence for roles of kappa-opioid and NMDA receptors in the mechanism of action of ibogaine (Q44345673) (← links)
- Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes (Q44345917) (← links)
- BIG news in alcohol addiction: new findings on growth factor pathways BDNF, insulin, and GDNF. (Q44592016) (← links)
- Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release (Q47962415) (← links)
- The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes (Q48175304) (← links)
- Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine (Q48301785) (← links)
- Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats (Q48420572) (← links)
- Alteration of electroencephalogram and monoamine concentrations in rat brain following ibogaine treatment (Q48427798) (← links)
- Neurochemical and neuroendocrine effects of ibogaine in rats: comparison to MK-801. (Q48428328) (← links)
- Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction (Q48527066) (← links)
- Sex Differences in Ibogaine Antagonism of Morphine-induced Locomotor Activity and in Ibogaine Brain Levels and Metabolism (Q48650618) (← links)
- Effects of chronic ibogaine treatment on cerebellar Purkinje cells in the rat (Q48683783) (← links)
- Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine. (Q48930416) (← links)